Ikhithi yokuxilonga ye-Antibody Subtype ukuya kwi-Helicobacter Pylori
Ulwazi lwemveliso
| Inombolo yoMfanekiso | HP-ab-s | Ukupakisha | Iimvavanyo ze-25 / ikiti, i-30kits / i-CTN |
| Igama | I-Antibody Subtype kwi-Helicobacter Pylori | Ukuhlelwa kwesixhobo | Iklasi I |
| Iimbonakalo | Uvakalelo oluphezulu, ukusebenza ngokulula | Isatifikethi | CE/ ISO13485 |
| Ukuchaneka | > 99% | Beka ubomi kwishelufa | Iminyaka emibini |
| Indlela yokusebenza | Fluorescence Immunochromatographic Assay | Inkonzo ye-OEM/ODM | Iyafumaneka |
Isishwankathelo
I-Helicobacter pylori ziibhaktheriya ezi-gram-negative, kwaye imilo ejikelezayo yokugoba inika igama le-helicobacterpylori. I-Helicobacter pylori ihlala kwiindawo ezahlukeneyo zesisu kunye ne-duodenum, eya kubangela ukudumba okungapheliyo kwe-gastric mucosa, izilonda zesisu kunye ne-duodenal, kunye nomhlaza wesisu. I-Arhente yaMazwe ngaMazwe yoPhando ngoMhlaza ichonge usulelo lwe-HP njengodidi lwe-carcinogen ngo-1994, kunye ne-cancerogenic HP ikakhulu iqulethe ii-cytotoxins ezimbini: enye yi-cytotoxin-enxulumene ne-CagA protein, enye i-vacuolating cytotoxin (VacA). I-HP inokohlulwa ibe ziindidi ezimbini ezisekelwe kwinkcazo yeCagA kunye neVacA: uhlobo lwe-toxigenic strain (ngokubonakalisa zombini iCagA kunye neVacA okanye nayiphi na enye yazo), eyona nto iyingozi kakhulu kwaye kulula ukubangela izifo zesisu; uhlobo lwe-II luyi-atoxigenic HP (ngaphandle kokubonakalisa zombini i-CagA kunye ne-VacA), enetyhefu encinci kwaye ayinayo impawu zonyango xa usulelo.
Uphawu:
• Uvakalelo oluphezulu
• iziphumo zokufunda kwimizuzu eli-15
• Ukusebenza ngokulula
• Ixabiso elithe ngqo kwifektri
• kufuneka umatshini wokufunda iziphumo
Injongo yokuSebenzisa
Le khithi isetyenziswa ekubhaqweni okusemgangathweni kwe-in vitro ye-antibody ye-Urease, i-antibody ye-CagA kunye ne-antibody ye-VacA kwi-helicobacter pylori kwigazi elipheleleyo lomntu, i-serum okanye isampuli ye-plasma, kwaye ikulungele ukuxilongwa kwe-HP kunye nokuchongwa kohlobo lwesigulana se-helicobacter pylori. usulelwe nge. Le khithi ibonelela kuphela iziphumo zovavanyo lwe-Urease antibody, i-CagA antibody kunye ne-VacA antibody kwi-helicobacter pylori, kwaye iziphumo ezifunyenweyo ziya kusetyenziswa ngokudityaniswa nolunye ulwazi lwekliniki ukuze luhlalutywe. Kufuneka isetyenziswe kuphela ngabasebenzi bezempilo.
Inkqubo yovavanyo
| 1 | I-1: Ukusetyenziswa kwe-immune analyzer ephathekayo |
| 2 | Vula i-aluminium foil bag package ye-reagent kwaye ukhuphe isixhobo sovavanyo. |
| 3 | Faka ngokuthe tye isixhobo sovavanyo kwi-slot ye-immune analyzer. |
| 4 | Kwiphepha lasekhaya le-interface yokusebenza ye-immune analyzer, cofa u-"Standard" ukufaka ujongano lovavanyo. |
| 5 | Cofa "QC Scan" ukuskena ikhowudi ye-QR kwicala langaphakathi lekhithi; igalelo kit ezinxulumene parameters kwisixhobo kwaye ukhethe uhlobo isampulu. Qaphela: Ibhetshi nganye inombolo yekhithi iya kuskenwa ngexesha elinye. Ukuba inombolo yebhetshi iskeniwe, ngoko tsiba eli nyathelo. |
| 6 | Khangela ukuhambelana "kweGama leMveliso", "Inombolo yeBatch" njl. |
| 7 | Qala ukongeza isampulu kwimeko yolwazi olungaguqukiyo:Inyathelo 1: ngokucotha pipette 80μL serum / plasma / isampuli igazi lonke ngaxeshanye, kwaye unikele ingqalelo hayi amaqamza pipette; Inyathelo lesi-2: isampulu yepipette kwisampulu yediluent, kwaye uxube ngokucokisekileyo isampulu kunye nesampulu yokuxutywa; Inyathelo lesi-3: i-pipette 80µL isisombululo esixutywe ngokucokisekileyo kwiqula lesixhobo sovavanyo, kwaye unike ingqwalasela akukho kumaqamza e-pipette. ngexesha lokuthatha isampuli |
| 8 | Emva kokudibanisa isampulu epheleleyo, cofa u-“Timing” kwaye ixesha eliseleyo lovavanyo liya kuboniswa ngokuzenzekelayo kumjongano. |
| 9 | Umhlalutyi we-Immune uya kugqiba uvavanyo kunye nohlalutyo ngokuzenzekelayo xa ixesha lokuvavanya lifikelelwe. |
| 10 | Emva kokuba uvavanyo lwe-immune analyser lugqityiwe, iziphumo zovavanyo ziya kuboniswa kujongano lovavanyo okanye zinokujongwa “kwiMbali” kwiphepha lasekhaya lojongano lokusebenza. |
